GMP Compliant Production of a Cryopreserved Adipose-Derived Stromal Cell Product for Feasible and Allogeneic Clinical Use
The emerging field of advanced therapy medicinal products (ATMP) holds promise of treating a variety of diseases. Adipose-derived stromal cells (ASCs) are currently being marketed or tested as cell-based therapies in numerous clinical trials. To ensure safety and efficacy of treatments, high-quality...
Saved in:
| Main Authors: | Mandana Haack-Sørensen, Ellen Mønsted Johansen, Lisbeth Drozd Højgaard, Jens Kastrup, Annette Ekblond |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2022/4664917 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mesenchymal stromal cells to treat patients with non‐ischaemic heart failure: Results from SCIENCE II pilot study
by: Abbas Ali Qayyum, et al.
Published: (2024-12-01) -
Retention and Functional Effect of Adipose-Derived Stromal Cells Administered in Alginate Hydrogel in a Rat Model of Acute Myocardial Infarction
by: Bjarke Follin, et al.
Published: (2018-01-01) -
Allogeneic mesenchymal stromal cell therapy on primary graft dysfunction after lung transplantation
by: Abbas Ali Qayyum, MD, MSc, PhD, et al.
Published: (2025-05-01) -
Lead-it-EAZY! GMP-compliant production of [212Pb]Pb-PSC-PEG2-TOC
by: Marc Pretze, et al.
Published: (2024-11-01) -
Expression of CD146 and Regenerative Cytokines by Human Placenta-Derived Mesenchymal Stromal Cells upon Expansion in Different GMP-Compliant Media
by: Frederik Peissert, et al.
Published: (2021-01-01)